Interview Questions for Oscar Flores, CEO at Genomcore and Made of Genes
Personalized medicine, a revolutionary approach to healthcare, is making waves in the industry, offering a new generation of medical services based on data-driven, molecular-based analysis. Two Spanish health tech companies, Genomcore and Made of Genes, are at the forefront of this movement, using artificial intelligence (AI) to enable personalized healthcare in the "real world."
The Power of Personalized Medicine
Personalized medicine delivers significant benefits by individualizing care, improving outcomes, and reducing costs. By considering an individual’s genetic makeup, lifestyle, and environment, tailored treatments and wellness solutions can lead to improved sleep, mood regulation, cognitive health, and even aging well through customized medications and compounds.
The benefits extend beyond the patient, too. By fostering trust, better communication, and a sense of being truly cared for, personalized medicine improves the patient experience and relationship. Better monitoring and intervention are also possible, with real-time sharing of patient data and test results among healthcare teams allowing prompt adjustments to care plans, reducing complications and supporting continuity of care.
Reducing Hospitalizations and Cost Savings
Personalized, preventive care models, enabled by connected health technologies, can also reduce emergency visits, hospital admissions, and overall costs by addressing health issues early. This proactive approach to healthcare can lead to a more sustainable system, with enhanced healthcare quality and long-term sustainability.
The Role of Better Data Access
The full potential of personalized medicine depends on robust, timely, and interoperable data access to support collaborative, data-driven healthcare delivery. Seamless, up-to-date sharing of patient genomic, clinical, and lifestyle data among multidisciplinary care teams and specialists is critical for tailoring prevention, diagnosis, and treatment plans effectively.
Informed decision-making through integrated genetic and biomarker data leads to early disease detection, targeted therapies, and continuous therapeutic monitoring. Addressing current gaps in care delivery, such as patients missing appropriate testing or facing delays in receiving targeted therapies, is also crucial. Improving data flow and coordination across healthcare settings can help bridge these gaps.
The Spanish Health Tech Pioneers
Genomcore and Made of Genes are leading the charge in personalized medicine. Genomcore's mission is to extract real value from data in a cost and time-effective manner, offering technological foundations to manage large sets of personal health data. Made of Genes aims to empower users to control their health data, offering a "plug and play" service for holistic molecular health assessment and providing non-clinical wellbeing and lifestyle recommendations.
However, the adoption of personalized medicine is not without challenges. A cultural change is needed, with both patients and professionals educated about the potential of personalized medicine to reduce the friction of adopting new data-driven solutions. The sector faces a low level of digitalization and interoperability, a lack of effective standards to exchange clinical data, and no systematic way to collect and structure information.
Despite these challenges, the future of personalized medicine looks bright. The amount of data generated by a health system is an indicator of its sophistication and a precursor of better health outcomes in the near future. The companies' approach opens the door to a new generation of therapies, assessments, and treatments based on molecular data, paving the way for a more personalized, effective, and sustainable healthcare system.
[1] Genomcore [2] Made of Genes [3] Personalized Medicine Coalition [4] European Commission [5] National Library of Medicine
- The Spanish health tech companies, Genomcore and Made of Genes, are leveraging data-driven, artificial intelligence (AI) for personalized healthcare, becoming trailblazers in the data-driven digital transformation of health-and-wellness.
- Genomcore is focused on extracting value from large sets of personal health data, offering data-and-cloud-computing solutions for improving the efficiency of personalized medicine.
- Made of Genes empowers users to take control of their health data through a comprehensive molecular health assessment service, providing personalized non-clinical wellbeing and lifestyle recommendations.
- As leaders in this movement, their ultimate goal is to revolutionize healthcare with a more data-driven, AI-enabled approach to health-and-wellness.
- As the reliance on data grows, science, technology, and innovation will be essential in addressing the challenges of improved data access and integration, fostering a culture that embraces personalized medicine for a more effective and sustainable healthcare system.
